Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy：a Single Center Analysis in the Real World

Mengnan Lv, Yi He, Donglin Yang, Qiaoling MA, Aiming Pang, Weihua Zhai, Jialin Wei, Xin Chen, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5900.

https://doi.org/10.1182/blood-2023-188534

Published: 2023

Journal Articles

A Real-World Efficacy of Letermovir Primary Prophylaxis for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single-Center Retrospective Analysis

Xiaoyu Zhang, Donglin Yang, Aiming Pang, Yi He, Jialin Wei, Rongli Zhang, Weihua Zhai, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 7027.

https://doi.org/10.1182/blood-2023-182816

Published: 2023

Journal Articles

A Modified Busulfan/Cyclophosphamide Preconditioning Regimen Incorporating Selinexor for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hematologic Malignancies

Xiaofei Ni, Weihua Zhai, AiMing Pang, Donglin Yang, Xin Chen, Qiaoling MA, Jialin Wei, Yi He, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 6974.

https://doi.org/10.1182/blood-2023-181449

Published: 2023

Journal Articles

Venetoclax Plus Azacitidine Versus Azacitidine Alone As Post-Transplant Maintenance Treatment in High-Risk AML and MDS

Yigeng Cao, Wenwen Guo, Weihua Zhai, Jialin Wei, Qiaoling MA, Donglin Yang, AiMing Pang, Mingzhe Han, Erlie Jiang

Blood (2023) 142 (Supplement 1): 4952.

https://doi.org/10.1182/blood-2023-180847

Published: 2023

Journal Articles

Analysis of Post-Transplant Clinical Outcomes and Prognostic Factors in FLT3-ITD Mutated Acute Myeloid Leukemia Patients Under ELN 2022 Risk Stratification

Chen Liang, Aiming Pang, Yi He, Donglin Yang, Rongli Zhang, Qiaoling MA, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 3619.

https://doi.org/10.1182/blood-2023-184582

Published: 2023

Journal Articles

The Efficacy and Safety of the Third Generation TKI Olverembatinib in Adult Ph+ Acute Lymphoblastic Leukemia with Relapsed Disease or Persistent MRD Bridging to Allo-HSCT: A Case Series from a Single Center

Xiaoyu Zhang, Yanhong Zhao, Rongli Zhang, Weihua Zhai, Yi He, Jialin Wei, Donglin Yang, Aiming Pang, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5892.

https://doi.org/10.1182/blood-2023-184400

Published: 2023

Journal Articles

Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia

Yanhong Zhao, Weihua Zhai, Aiming Pang, Donglin Yang, Yi He, Jialin Wei, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5893.

https://doi.org/10.1182/blood-2023-184565

Published: 2023

Journal Articles

Combination of Cytogenetic Classification and MRD Status Correlates with Outcomes of Autologous Versus Allogeneic Stem Cell Transplantation in Adults with B Cell-Acute Lymphoblastic Leukemia in First Remission

Rongli Zhang, Mengnan Lyu, Yi He, Donglin Yang, Aiming Pang, Jialin Wei, Qiaoling Ma, Weihua Zhai, Xin Chen, Guixin Zhang, Sizhou Feng, Mingzhe Han, Erlie Jiang

Blood (2022) 140 (Supplement 1): 7714–7715.

https://doi.org/10.1182/blood-2022-165085

Published: 2022

Journal Articles

Long-Term Efficacy Analysis of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia Using Melphalan Instead of Cyclophosphamide As a Myeloablative Conditioning Regimen

Ying Zhang, Aiming Pang, Donglin Yang, Yong Huang, Jialin Wei, Yi He, Qiaoling Ma, Sizhou Feng, Mingzhe Han, Erlie Jiang

Blood (2022) 140 (Supplement 1): 12842–12843.

https://doi.org/10.1182/blood-2022-167070

Published: 2022

Journal Articles

A Report of Fourcases of Severethrombocytopenia with Rh G-CSF Mobilized Allogeneic Peripheral Blood Stem Cell Transplant Donors

Qingzhen Liu, Jianfeng Yao, Donglin Yang, Aiming Pang, MD PhD, Erlie Jiang, Sizhou Feng, MDPhD, Ming-Zhe Han, MD

Blood (2020) 136 (Supplement 1): 22.

https://doi.org/10.1182/blood-2020-141209

Published: 2020

Journal Articles

Long-Term Outcomes Following Donor-Derived Anti-CD19 CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia Patients Relapsed after Allogenic Stem Cell Transplantation

Rongli Zhang, MD, Ying Wang, MD, Dehui Zou, MD, Erlie Jiang, Yi He, Donglin Yang, Sizhou Feng, MD, Jianxiang Wang, MD, Ming-Zhe Han

Blood (2020) 136 (Supplement 1): 53–54.

https://doi.org/10.1182/blood-2020-133486

Published: 2020

Journal Articles

Oral Posaconazole or Intravenous-Oral Itraconazole in Preventing Invasive Fungal Diseases for Patients with Acute Leukemia

Li Liu, Xiaolei Pei, Runzhi Ma, Yi He, Rongli Zhang, MD, Jialin Wei, Qiaoling Ma, Weihua Zhai, MD, Erlie Jiang, Aiming Pang, MD PhD, Donglin Yang, Sizhou Feng, MDPhD, Ming-Zhe Han, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-141508

Published: 2020

Journal Articles

Prognostic Prediction Clinical-Molecular Model for Allogeneic Transplant Outcomes in Patients with Myelodysplastic Syndrome

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-140676

Published: 2020

Journal Articles

Donor-Derived Second Generation of CD19 CAR-T Cell Therapy for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogenic Stem Cell Transplantation

Rongli Zhang, MD, Yi He, Donglin Yang, Ying Wang, MD, Sizhou Feng, MD, Jianxiang Wang, MD, Ming-Zhe Han, MD

Blood (2018) 132 (Supplement 1): 2179.

https://doi.org/10.1182/blood-2018-99-114950

Published: 2018

Journal Articles

Children Transient Pancytopenia Preceding Hybrid Acute Leukemia

Donglin Yang, Yusheng Bai, Lan Qin, Xiaojun Du, Xihu Ma, Wei Liu, Sizhou Feng, Ming-Zhe Han

Blood (2008) 112 (11): 3945.

https://doi.org/10.1182/blood.V112.11.3945.3945

Published: 2008

NARROW

Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy：a Single Center Analysis in the Real World

A Real-World Efficacy of Letermovir Primary Prophylaxis for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single-Center Retrospective Analysis

A Modified Busulfan/Cyclophosphamide Preconditioning Regimen Incorporating Selinexor for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hematologic Malignancies

Venetoclax Plus Azacitidine Versus Azacitidine Alone As Post-Transplant Maintenance Treatment in High-Risk AML and MDS

Analysis of Post-Transplant Clinical Outcomes and Prognostic Factors in FLT3-ITD Mutated Acute Myeloid Leukemia Patients Under ELN 2022 Risk Stratification

The Efficacy and Safety of the Third Generation TKI Olverembatinib in Adult Ph+ Acute Lymphoblastic Leukemia with Relapsed Disease or Persistent MRD Bridging to Allo-HSCT: A Case Series from a Single Center

Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia

Combination of Cytogenetic Classification and MRD Status Correlates with Outcomes of Autologous Versus Allogeneic Stem Cell Transplantation in Adults with B Cell-Acute Lymphoblastic Leukemia in First Remission

Long-Term Efficacy Analysis of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia Using Melphalan Instead of Cyclophosphamide As a Myeloablative Conditioning Regimen

A Report of Fourcases of Severethrombocytopenia with Rh G-CSF Mobilized Allogeneic Peripheral Blood Stem Cell Transplant Donors

Long-Term Outcomes Following Donor-Derived Anti-CD19 CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia Patients Relapsed after Allogenic Stem Cell Transplantation

Oral Posaconazole or Intravenous-Oral Itraconazole in Preventing Invasive Fungal Diseases for Patients with Acute Leukemia

Prognostic Prediction Clinical-Molecular Model for Allogeneic Transplant Outcomes in Patients with Myelodysplastic Syndrome

Donor-Derived Second Generation of CD19 CAR-T Cell Therapy for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogenic Stem Cell Transplantation

Children Transient Pancytopenia Preceding Hybrid Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only